Myovant Sciences aspires to be the leading healthcare company focused on redefining care for women and for men. We are on a mission to develop and deliver empowering medicines for women's health and prostate cancer through purpose-driven science and transformative advocacy. We are looking for passionate and hard-working individuals who share our excitement for this mission. We are currently seeking a qualified, highly motivated, experienced individual for the position of Associate Director, Corporate Communications (Prostate Cancer) . The position is located in Brisbane, California. Position Summary The Associate Director, Corporate Communications (Prostate Cancer) will be responsible for the creation and oversight of communications strategies, programs, and messaging for prostate cancer. The primary responsibility for this role will be to drive content for Myovant's corporate platforms including product launch initiatives and R&D milestones. The individual will...
Jul 24, 2021
Full time
Myovant Sciences aspires to be the leading healthcare company focused on redefining care for women and for men. We are on a mission to develop and deliver empowering medicines for women's health and prostate cancer through purpose-driven science and transformative advocacy. We are looking for passionate and hard-working individuals who share our excitement for this mission. We are currently seeking a qualified, highly motivated, experienced individual for the position of Associate Director, Corporate Communications (Prostate Cancer) . The position is located in Brisbane, California. Position Summary The Associate Director, Corporate Communications (Prostate Cancer) will be responsible for the creation and oversight of communications strategies, programs, and messaging for prostate cancer. The primary responsibility for this role will be to drive content for Myovant's corporate platforms including product launch initiatives and R&D milestones. The individual will...
Myovant Sciences aspires to be the leading healthcare company focused on innovative treatments for women's health and prostate cancer designed to improve the lives of millions. We are on a mission to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy. We are looking for passionate and enthusiastic individuals who share our excitement for this mission. Summary Description We are currently seeking a dynamic, highly motivated, and experienced individual for the position of Associate Director, Pharmacovigilance Alliance Management located at our Brisbane office. The position is responsible for managing pharmacovigilance-related work with Myovant contractual partners, vendors responsible for safety data collection, and internal functional lines. The Associate Director, Pharmacovigilance Alliance Management, has a leadership role in the development, implementation and maintenance of pharmacovigilance agreements...
Jul 24, 2021
Full time
Myovant Sciences aspires to be the leading healthcare company focused on innovative treatments for women's health and prostate cancer designed to improve the lives of millions. We are on a mission to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy. We are looking for passionate and enthusiastic individuals who share our excitement for this mission. Summary Description We are currently seeking a dynamic, highly motivated, and experienced individual for the position of Associate Director, Pharmacovigilance Alliance Management located at our Brisbane office. The position is responsible for managing pharmacovigilance-related work with Myovant contractual partners, vendors responsible for safety data collection, and internal functional lines. The Associate Director, Pharmacovigilance Alliance Management, has a leadership role in the development, implementation and maintenance of pharmacovigilance agreements...
Myovant Sciences aspires to be the leading healthcare company focused on innovative treatments for women's health and prostate cancer designed to improve the lives of millions. We are on a mission to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy. We are looking for passionate and self-driven individuals who share our excitement for this mission. We are embarking on a multi-year ambitious journey of building a best in class SAP platform aligned with our strategic corporate roadmap. We are looking for an SAP Supply Chain Functional Lead who will play a critical role in enabling this vision. The ideal candidate possesses in-depth SAP functional knowledge and an aptitude for supply chain process and systems in SD/MM/QM modules. You will identify, design, and build technology-driven solutions that enable strategic initiatives and operational improvements, including the implementation of SAP S/4HANA ERP. In this...
Jul 24, 2021
Full time
Myovant Sciences aspires to be the leading healthcare company focused on innovative treatments for women's health and prostate cancer designed to improve the lives of millions. We are on a mission to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy. We are looking for passionate and self-driven individuals who share our excitement for this mission. We are embarking on a multi-year ambitious journey of building a best in class SAP platform aligned with our strategic corporate roadmap. We are looking for an SAP Supply Chain Functional Lead who will play a critical role in enabling this vision. The ideal candidate possesses in-depth SAP functional knowledge and an aptitude for supply chain process and systems in SD/MM/QM modules. You will identify, design, and build technology-driven solutions that enable strategic initiatives and operational improvements, including the implementation of SAP S/4HANA ERP. In this...
Myovant Sciences aspires to be the leading healthcare company focused on innovative treatments for women's health and prostate cancer designed to improve the lives of millions. We are on a mission to develop and deliver empowering medicines for women's health and prostate cancer through purpose-driven science and transformative advocacy. We are looking for passionate and hard-working individuals who share our excitement for this mission. We are currently seeking a qualified, highly motivated, experienced individual for the position of Marketing Operations Specialist . The position reports to the Senior Manager, Marketing Operations . The location of the position is in Brisbane, CA. Summary Description The Marketing Operations Specialist will focus on managing the Medical, Legal, Regulatory (MLR) promotional material review process for an assigned therapeutic area. This role will partner as a liaison between the brand team and MLR reviewers to enhance the MLR process and...
Jul 24, 2021
Full time
Myovant Sciences aspires to be the leading healthcare company focused on innovative treatments for women's health and prostate cancer designed to improve the lives of millions. We are on a mission to develop and deliver empowering medicines for women's health and prostate cancer through purpose-driven science and transformative advocacy. We are looking for passionate and hard-working individuals who share our excitement for this mission. We are currently seeking a qualified, highly motivated, experienced individual for the position of Marketing Operations Specialist . The position reports to the Senior Manager, Marketing Operations . The location of the position is in Brisbane, CA. Summary Description The Marketing Operations Specialist will focus on managing the Medical, Legal, Regulatory (MLR) promotional material review process for an assigned therapeutic area. This role will partner as a liaison between the brand team and MLR reviewers to enhance the MLR process and...
COMPANY Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. By leveraging its internal research and development and exclusive licensing to patents related to Cas12, Cas13, Cas14 and CasPhi, Mammoth Biosciences is advancing disease detection and treatment using its novel CRISPR systems that can deliver on the promise of precision medicine across diagnostics and therapeutics. Furthermore, Mammoth's CRISPR technology platform will enable new solutions in life science research, healthcare, agriculture, biodefense and more. Based in the San Francisco Bay Area, Mammoth Biosciences is co-founded by CRISPR pioneer and Nobel Prize winner Jennifer Doudna and principal founders Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors...
Jul 23, 2021
Full time
COMPANY Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. By leveraging its internal research and development and exclusive licensing to patents related to Cas12, Cas13, Cas14 and CasPhi, Mammoth Biosciences is advancing disease detection and treatment using its novel CRISPR systems that can deliver on the promise of precision medicine across diagnostics and therapeutics. Furthermore, Mammoth's CRISPR technology platform will enable new solutions in life science research, healthcare, agriculture, biodefense and more. Based in the San Francisco Bay Area, Mammoth Biosciences is co-founded by CRISPR pioneer and Nobel Prize winner Jennifer Doudna and principal founders Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors...
Manager : CFO Department: Finance Location: Brisbane, CA Sangamo Therapeutics is a genomic medicine company building value with cutting-edge work across four distinct but complementary technology platforms - gene therapy, cell therapy, in vivo genome editing, and in vivo genome regulation. Using its deep scientific expertise and proprietary zinc finger genome engineering technology, Sangamo is working to create genomic cures for patients suffering from severe genetic diseases for which today's medicines can only treat symptoms. At Sangamo, we are passionate about transforming lives by building a robust, sustainable, differentiated, innovative, and high value genomic medicine pipeline that addresses patients with life-limiting conditions. Sangamo takes pride in being the first to edit endogenous human genes, first to treat patients with gene edited T cells, and first to treat patients with in vivo genome editing. Our top priority is to meet the need of patients with...
Jul 23, 2021
Full time
Manager : CFO Department: Finance Location: Brisbane, CA Sangamo Therapeutics is a genomic medicine company building value with cutting-edge work across four distinct but complementary technology platforms - gene therapy, cell therapy, in vivo genome editing, and in vivo genome regulation. Using its deep scientific expertise and proprietary zinc finger genome engineering technology, Sangamo is working to create genomic cures for patients suffering from severe genetic diseases for which today's medicines can only treat symptoms. At Sangamo, we are passionate about transforming lives by building a robust, sustainable, differentiated, innovative, and high value genomic medicine pipeline that addresses patients with life-limiting conditions. Sangamo takes pride in being the first to edit endogenous human genes, first to treat patients with gene edited T cells, and first to treat patients with in vivo genome editing. Our top priority is to meet the need of patients with...
QED Therapeutics, a subsidiary of BridgeBio Services , focuses on precision medicine for FGFR-driven cancers and diseases. The company's first therapy, TRUSELTIQTM (infigratinib), is an orally administered FGFR1-3 tyrosine kinase inhibitor that the US FDA recently approved for the treatment of patients with previously treated locally advanced or metastatic cholangiocarcinoma (CCA) harboring an FGFR2 fusion or rearrangement. We are also evaluating infigratinib for the treatment of other FGFR-driven cancers as well as for the treatment of achondroplasia and other skeletal dysplasias. QED is derived from the Latin "Quod Erat Demonstrandum" -Thus; It Has Been Proven. Our business is inspired by our values: PUT PATIENTS FIRST LET SCIENCE SPEAK EVERY MINUTE COUNTS THINK INDEPENDENTLY BE RADICALLY TRANSPARENT FGFR=fibroblast growth factor receptor. BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases. The company bridges remarkable advancements...
Jul 22, 2021
Full time
QED Therapeutics, a subsidiary of BridgeBio Services , focuses on precision medicine for FGFR-driven cancers and diseases. The company's first therapy, TRUSELTIQTM (infigratinib), is an orally administered FGFR1-3 tyrosine kinase inhibitor that the US FDA recently approved for the treatment of patients with previously treated locally advanced or metastatic cholangiocarcinoma (CCA) harboring an FGFR2 fusion or rearrangement. We are also evaluating infigratinib for the treatment of other FGFR-driven cancers as well as for the treatment of achondroplasia and other skeletal dysplasias. QED is derived from the Latin "Quod Erat Demonstrandum" -Thus; It Has Been Proven. Our business is inspired by our values: PUT PATIENTS FIRST LET SCIENCE SPEAK EVERY MINUTE COUNTS THINK INDEPENDENTLY BE RADICALLY TRANSPARENT FGFR=fibroblast growth factor receptor. BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases. The company bridges remarkable advancements...
QED Therapeutics, a subsidiary of BridgeBio Services , focuses on precision medicine for FGFR-driven cancers and diseases. The company's first therapy, TRUSELTIQTM (infigratinib), is an orally administered FGFR1-3 tyrosine kinase inhibitor that the US FDA recently approved for the treatment of patients with previously treated locally advanced or metastatic cholangiocarcinoma (CCA) harboring an FGFR2 fusion or rearrangement. We are also evaluating infigratinib for the treatment of other FGFR-driven cancers as well as for the treatment of achondroplasia and other skeletal dysplasias. QED is derived from the Latin "Quod Erat Demonstrandum" -Thus; It Has Been Proven. Our business is inspired by our values: PUT PATIENTS FIRST LET SCIENCE SPEAK EVERY MINUTE COUNTS THINK INDEPENDENTLY BE RADICALLY TRANSPARENT FGFR=fibroblast growth factor receptor. BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases. The company bridges remarkable advancements...
Jul 22, 2021
Full time
QED Therapeutics, a subsidiary of BridgeBio Services , focuses on precision medicine for FGFR-driven cancers and diseases. The company's first therapy, TRUSELTIQTM (infigratinib), is an orally administered FGFR1-3 tyrosine kinase inhibitor that the US FDA recently approved for the treatment of patients with previously treated locally advanced or metastatic cholangiocarcinoma (CCA) harboring an FGFR2 fusion or rearrangement. We are also evaluating infigratinib for the treatment of other FGFR-driven cancers as well as for the treatment of achondroplasia and other skeletal dysplasias. QED is derived from the Latin "Quod Erat Demonstrandum" -Thus; It Has Been Proven. Our business is inspired by our values: PUT PATIENTS FIRST LET SCIENCE SPEAK EVERY MINUTE COUNTS THINK INDEPENDENTLY BE RADICALLY TRANSPARENT FGFR=fibroblast growth factor receptor. BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases. The company bridges remarkable advancements...
Manager: Sr. Director, Analytical Development Department: Analytical Development, Technical Operations Location: Brisbane, CA Sangamo Therapeutics is a genomic medicine company building value with cutting-edge work across four distinct but complementary technology platforms - gene therapy, cell therapy, in vivo genome editing, and in vivo genome regulation. At Sangamo, we are passionate in developing genomic medicines to transform the lives of patients with serious diseases. We transform lives by building a robust, sustainable, differentiated, innovative, and high value genomic medicine pipeline that addresses patients with life-limiting conditions. Sangamo takes pride in being the first to edit endogenous human genes, first to treat patients with gene edited T cells, and first to treat patients with in vivo genome editing. Our top priority is to meet the needs of patients with commitment and compassion. Along with our commitment to science and to our patients, we...
Jul 21, 2021
Full time
Manager: Sr. Director, Analytical Development Department: Analytical Development, Technical Operations Location: Brisbane, CA Sangamo Therapeutics is a genomic medicine company building value with cutting-edge work across four distinct but complementary technology platforms - gene therapy, cell therapy, in vivo genome editing, and in vivo genome regulation. At Sangamo, we are passionate in developing genomic medicines to transform the lives of patients with serious diseases. We transform lives by building a robust, sustainable, differentiated, innovative, and high value genomic medicine pipeline that addresses patients with life-limiting conditions. Sangamo takes pride in being the first to edit endogenous human genes, first to treat patients with gene edited T cells, and first to treat patients with in vivo genome editing. Our top priority is to meet the needs of patients with commitment and compassion. Along with our commitment to science and to our patients, we...
Myovant Sciences aspires to be the leading healthcare company focused on innovative treatments for women's health and prostate cancer designed to improve the lives of millions. We are on a mission to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy. We are looking for passionate and enthusiastic individuals who share our excitement for this mission. We are currently seeking a qualified, highly motivated, experienced individual for the position of Senior Manager, HCP Marketing for Women's Health . The position will report to the Director, HCP Marketing & Franchise Strategy for Women's Health . The location of the position is Brisbane, CA. Summary Description The Senior Manager, HCP Marketing for Women's Health will lead key commercial initiatives to drive success in the launch of Myfembree for heavy menstrual bleeding associated with uterine fibroids. S/he will also help develop and execute...
Jul 21, 2021
Full time
Myovant Sciences aspires to be the leading healthcare company focused on innovative treatments for women's health and prostate cancer designed to improve the lives of millions. We are on a mission to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy. We are looking for passionate and enthusiastic individuals who share our excitement for this mission. We are currently seeking a qualified, highly motivated, experienced individual for the position of Senior Manager, HCP Marketing for Women's Health . The position will report to the Director, HCP Marketing & Franchise Strategy for Women's Health . The location of the position is Brisbane, CA. Summary Description The Senior Manager, HCP Marketing for Women's Health will lead key commercial initiatives to drive success in the launch of Myfembree for heavy menstrual bleeding associated with uterine fibroids. S/he will also help develop and execute...
QED Therapeutics, a subsidiary of BridgeBio Services , focuses on precision medicine for FGFR-driven cancers and diseases. The company's first therapy, TRUSELTIQTM (infigratinib), is an orally administered FGFR1-3 tyrosine kinase inhibitor that the US FDA recently approved for the treatment of patients with previously treated locally advanced or metastatic cholangiocarcinoma (CCA) harboring an FGFR2 fusion or rearrangement. We are also evaluating infigratinib for the treatment of other FGFR-driven cancers as well as for the treatment of achondroplasia and other skeletal dysplasias. QED is derived from the Latin "Quod Erat Demonstrandum" -Thus; It Has Been Proven. Our business is inspired by our values: PUT PATIENTS FIRST LET SCIENCE SPEAK EVERY MINUTE COUNTS THINK INDEPENDENTLY BE RADICALLY TRANSPARENT FGFR=fibroblast growth factor receptor. BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases. The company bridges remarkable advancements in...
Jul 21, 2021
Full time
QED Therapeutics, a subsidiary of BridgeBio Services , focuses on precision medicine for FGFR-driven cancers and diseases. The company's first therapy, TRUSELTIQTM (infigratinib), is an orally administered FGFR1-3 tyrosine kinase inhibitor that the US FDA recently approved for the treatment of patients with previously treated locally advanced or metastatic cholangiocarcinoma (CCA) harboring an FGFR2 fusion or rearrangement. We are also evaluating infigratinib for the treatment of other FGFR-driven cancers as well as for the treatment of achondroplasia and other skeletal dysplasias. QED is derived from the Latin "Quod Erat Demonstrandum" -Thus; It Has Been Proven. Our business is inspired by our values: PUT PATIENTS FIRST LET SCIENCE SPEAK EVERY MINUTE COUNTS THINK INDEPENDENTLY BE RADICALLY TRANSPARENT FGFR=fibroblast growth factor receptor. BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases. The company bridges remarkable advancements in...
Company Description You aren't looking for a job, you're looking for a career, a future. It doesn't matter if you are a seasoned professional or freshly entering the workforce, if you desire an opportunity to learn and grow, then Expeditors is the company you should keep. We value long-term employment for what it can do for our customers and for career satisfaction. Jeff Musser, our president and CEO, started as an entry-level employee in our San Francisco office 34 years ago. We love to promote from within-more than a quarter of our 16,000+ employees have been at Expeditors 10 years or more. Our high retention rate is influenced by our extraordinary culture and a unique compensation program. 18,000 trained professionals 250+ locations worldwide Fortune 500 Globally unified systems Job Description Maintain positive, strong relationships with customers and suppliers (Airline carriers, trucking companies and others involved) Ability to read client specific...
Jul 20, 2021
Full time
Company Description You aren't looking for a job, you're looking for a career, a future. It doesn't matter if you are a seasoned professional or freshly entering the workforce, if you desire an opportunity to learn and grow, then Expeditors is the company you should keep. We value long-term employment for what it can do for our customers and for career satisfaction. Jeff Musser, our president and CEO, started as an entry-level employee in our San Francisco office 34 years ago. We love to promote from within-more than a quarter of our 16,000+ employees have been at Expeditors 10 years or more. Our high retention rate is influenced by our extraordinary culture and a unique compensation program. 18,000 trained professionals 250+ locations worldwide Fortune 500 Globally unified systems Job Description Maintain positive, strong relationships with customers and suppliers (Airline carriers, trucking companies and others involved) Ability to read client specific...
BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases. The company bridges remarkable advancements in genetic science with the entrepreneurial engine required to rapidly create lifesaving medicines for patients with unmet needs. Founded in 2015 by a team of industry veterans, the company has built a portfolio of 20 transformative drugs ranging from pre-clinical to late-stage development in multiple therapeutic areas including genetic dermatology, oncology, cardiology, neurology, endocrinology, renal disease, and ophthalmology. The company's focus on scientific excellence and rapid execution aims to translate today's discoveries into tomorrow's medicines. We have offices in San Francisco, Palo Alto, Boston, New York, and Raleigh, with small satellites in other parts of the country. To learn more, visit us at Who You Are: The Corporate Controller plays a leadership role in the accounting and financial reporting functions and has the...
Jul 19, 2021
Full time
BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases. The company bridges remarkable advancements in genetic science with the entrepreneurial engine required to rapidly create lifesaving medicines for patients with unmet needs. Founded in 2015 by a team of industry veterans, the company has built a portfolio of 20 transformative drugs ranging from pre-clinical to late-stage development in multiple therapeutic areas including genetic dermatology, oncology, cardiology, neurology, endocrinology, renal disease, and ophthalmology. The company's focus on scientific excellence and rapid execution aims to translate today's discoveries into tomorrow's medicines. We have offices in San Francisco, Palo Alto, Boston, New York, and Raleigh, with small satellites in other parts of the country. To learn more, visit us at Who You Are: The Corporate Controller plays a leadership role in the accounting and financial reporting functions and has the...
Manager: Associate Director, Cell Culture Process Development Department: Process Development, Technical Operations Location: Brisbane, CA Sangamo Therapeutics is a genomic medicine company building value with cutting-edge work across four distinct but complementary technology platforms - gene therapy, cell therapy, in vivo genome editing, and in vivo genome regulation. At Sangamo, we are passionate in developing genomic medicines to transform the lives of patients with serious diseases. We transform lives by building a robust, sustainable, differentiated, innovative, and high value genomic medicine pipeline that addresses patients with life-limiting conditions. Sangamo takes pride in being the first to edit endogenous human genes, first to treat patients with gene edited T cells, and first to treat patients with in vivo genome editing. Our top priority is to meet the needs of patients with commitment and compassion. Along with our commitment to science and to our...
Jul 19, 2021
Full time
Manager: Associate Director, Cell Culture Process Development Department: Process Development, Technical Operations Location: Brisbane, CA Sangamo Therapeutics is a genomic medicine company building value with cutting-edge work across four distinct but complementary technology platforms - gene therapy, cell therapy, in vivo genome editing, and in vivo genome regulation. At Sangamo, we are passionate in developing genomic medicines to transform the lives of patients with serious diseases. We transform lives by building a robust, sustainable, differentiated, innovative, and high value genomic medicine pipeline that addresses patients with life-limiting conditions. Sangamo takes pride in being the first to edit endogenous human genes, first to treat patients with gene edited T cells, and first to treat patients with in vivo genome editing. Our top priority is to meet the needs of patients with commitment and compassion. Along with our commitment to science and to our...
At Bristol Myers Squibb, we are inspired by a single vision - transforming patients' lives through science. In oncology, hematology, immunology and cardiovascular disease - and one of the most diverse and promising pipelines in the industry - each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference. We are seeking an experienced, knowledgeable, and self-motivated Scientist to join our Protein Sciences team within the company's Research Division. Key accountabilities in this position will include expressing, purifying, characterize and delivery of native and recombinant proteins to support Lead-op, HTS, mechanism of action studies, and crystallography for different programs within the BMS organization. This position would entail ~70-80% laboratory presence with the rest of the time spent in data analysis, data organization, and presenting data in meetings and to key...
Jul 18, 2021
Full time
At Bristol Myers Squibb, we are inspired by a single vision - transforming patients' lives through science. In oncology, hematology, immunology and cardiovascular disease - and one of the most diverse and promising pipelines in the industry - each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference. We are seeking an experienced, knowledgeable, and self-motivated Scientist to join our Protein Sciences team within the company's Research Division. Key accountabilities in this position will include expressing, purifying, characterize and delivery of native and recombinant proteins to support Lead-op, HTS, mechanism of action studies, and crystallography for different programs within the BMS organization. This position would entail ~70-80% laboratory presence with the rest of the time spent in data analysis, data organization, and presenting data in meetings and to key...
Myovant Sciences aspires to be the leading healthcare company focused on innovative treatments for women's health and prostate cancer designed to improve the lives of millions. We are on a mission to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy. We are looking for passionate and hard-working individuals who share our excitement for this mission. We are currently seeking a qualified, highly motivated, experienced individual for the position of Payroll Accountant/Senior Payroll Accountant. The location of the position is onsite in Brisbane, CA. Summary Description As a member of the payroll team, this individual will be responsible for processing and recording of company's payroll, provide timely and accurate financial information, and participate in daily data entry Payroll processing. This position will impact a rapidly growing organization and offers career development opportunities for the right...
Jul 16, 2021
Full time
Myovant Sciences aspires to be the leading healthcare company focused on innovative treatments for women's health and prostate cancer designed to improve the lives of millions. We are on a mission to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy. We are looking for passionate and hard-working individuals who share our excitement for this mission. We are currently seeking a qualified, highly motivated, experienced individual for the position of Payroll Accountant/Senior Payroll Accountant. The location of the position is onsite in Brisbane, CA. Summary Description As a member of the payroll team, this individual will be responsible for processing and recording of company's payroll, provide timely and accurate financial information, and participate in daily data entry Payroll processing. This position will impact a rapidly growing organization and offers career development opportunities for the right...
BioSpace has been engaged to help our client, a biopharmaceutical company whose lead programs are focused on the elimination or modulation of senescent cells in diseased tissues as a means of providing transformative therapeutics for patients with ophthalmological or neurological diseases. About the role: Leadership role - head the In Vivo Pharmacology group, lead the strategy for the group Execute in vivo studies, derive data for programs in ophthalmology and neurology Design PK/PD/efficacy studies in preclinical models, including molecule and biochemical endpoints Mentor and lead the scientists and RAs within the group Ideal Candidate: Track record in drug discovery, specifically including the characterization of disease-relevant pathways and pharmacological activity of novel molecules in preclinical disease models experience ranging from target identification/validation, lead optimization, translational pharmacology, to IND submission...
Jul 16, 2021
Full time
BioSpace has been engaged to help our client, a biopharmaceutical company whose lead programs are focused on the elimination or modulation of senescent cells in diseased tissues as a means of providing transformative therapeutics for patients with ophthalmological or neurological diseases. About the role: Leadership role - head the In Vivo Pharmacology group, lead the strategy for the group Execute in vivo studies, derive data for programs in ophthalmology and neurology Design PK/PD/efficacy studies in preclinical models, including molecule and biochemical endpoints Mentor and lead the scientists and RAs within the group Ideal Candidate: Track record in drug discovery, specifically including the characterization of disease-relevant pathways and pharmacological activity of novel molecules in preclinical disease models experience ranging from target identification/validation, lead optimization, translational pharmacology, to IND submission...
Our client is seeking to hire a Senior Research Associate for their Immunohistochemistry and Analytical Histology group. This position will afford the successful individual an opportunity to help discover and develop innovative drugs to modulate an emerging and exciting biological concept in diseases of aging and to translate our science into a pipeline of differentiated medicines. The successful candidate will be a strong individual contributor. The duties of the job include experimental design and execution, analysis and interpretation of data, regular presentations (verbal/written) of results and interpretation at group, project team, and Discovery team meetings. Title/compensation will be based on experience. Responsibilities: Experimental design of histology experiments. Perform histological stains, IHC / IF, or ISH on mouse and human tissue utilizing both manual and automated platforms. Slide imaging and fluorescence microscopy. Image quantification and...
Jul 16, 2021
Full time
Our client is seeking to hire a Senior Research Associate for their Immunohistochemistry and Analytical Histology group. This position will afford the successful individual an opportunity to help discover and develop innovative drugs to modulate an emerging and exciting biological concept in diseases of aging and to translate our science into a pipeline of differentiated medicines. The successful candidate will be a strong individual contributor. The duties of the job include experimental design and execution, analysis and interpretation of data, regular presentations (verbal/written) of results and interpretation at group, project team, and Discovery team meetings. Title/compensation will be based on experience. Responsibilities: Experimental design of histology experiments. Perform histological stains, IHC / IF, or ISH on mouse and human tissue utilizing both manual and automated platforms. Slide imaging and fluorescence microscopy. Image quantification and...
The ideal candidate will be a self-directed and motivated researcher with experience in the areas of cell biology and in vitro pharmacology. This position requires a strong lab-based individual contributor who is adept at working within cross-functional project teams. The duties of the job include experimental design and execution, analysis and interpretation of data, and presentation (verbal/written) of findings to the larger Discovery organization. The candidate will have an important role in the generation of key datasets that are critical for the selection of clinical development candidates. REQUIREMENTS: Bachelor's degree in the Life Sciences with 5-10 years of scientific experience in the biopharmaceutical industry, a Master's degree and 2-6 years of experience. Strong track record for scientific and technical independence, and an experienced lab-based researcher with an excellent foundation in working with antibody-based detection assays/techniques (Flow...
Jul 16, 2021
Full time
The ideal candidate will be a self-directed and motivated researcher with experience in the areas of cell biology and in vitro pharmacology. This position requires a strong lab-based individual contributor who is adept at working within cross-functional project teams. The duties of the job include experimental design and execution, analysis and interpretation of data, and presentation (verbal/written) of findings to the larger Discovery organization. The candidate will have an important role in the generation of key datasets that are critical for the selection of clinical development candidates. REQUIREMENTS: Bachelor's degree in the Life Sciences with 5-10 years of scientific experience in the biopharmaceutical industry, a Master's degree and 2-6 years of experience. Strong track record for scientific and technical independence, and an experienced lab-based researcher with an excellent foundation in working with antibody-based detection assays/techniques (Flow...
QED Therapeutics, a subsidiary of BridgeBio Services , focuses on precision medicine for FGFR-driven cancers and diseases. The company's first therapy, TRUSELTIQTM (infigratinib), is an orally administered FGFR1-3 tyrosine kinase inhibitor that was recently approved by the US FDA for the treatment of patients with previously-treated locally advanced or metastatic cholangiocarcinoma (CCA) harboring an FGFR2 fusion or rearrangement. We are also evaluating infigratinib for the treatment of other FGFR-driven cancers as well as for the treatment of achondroplasia and other skeletal dysplasias. QED is derived from the Latin "Quod Erat Demonstrandum" -Thus, It Has Been Proven. Our business is inspired by our values: PUT PATIENTS FIRST LET SCIENCE SPEAK EVERY MINUTE COUNTS THINK INDEPENDENTLY BE RADICALLY TRANSPARENT FGFR=fibroblast growth factor receptor. BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases. The company bridges remarkable...
Jul 10, 2021
Full time
QED Therapeutics, a subsidiary of BridgeBio Services , focuses on precision medicine for FGFR-driven cancers and diseases. The company's first therapy, TRUSELTIQTM (infigratinib), is an orally administered FGFR1-3 tyrosine kinase inhibitor that was recently approved by the US FDA for the treatment of patients with previously-treated locally advanced or metastatic cholangiocarcinoma (CCA) harboring an FGFR2 fusion or rearrangement. We are also evaluating infigratinib for the treatment of other FGFR-driven cancers as well as for the treatment of achondroplasia and other skeletal dysplasias. QED is derived from the Latin "Quod Erat Demonstrandum" -Thus, It Has Been Proven. Our business is inspired by our values: PUT PATIENTS FIRST LET SCIENCE SPEAK EVERY MINUTE COUNTS THINK INDEPENDENTLY BE RADICALLY TRANSPARENT FGFR=fibroblast growth factor receptor. BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases. The company bridges remarkable...
